Impact of TAVI on Mitral Regurgitation: A Prospective Echocardiographic Study
- 27 November 2012
- journal article
- research article
- Published by Wiley in Echocardiography
- Vol. 30 (3), 250-257
- https://doi.org/10.1111/echo.12050
Abstract
Objective: This study aims to assess changes in mitral regurgitation (MR) severity after transcatheter aortic valve implantation (TAVI). Background: Existing data on MR after TAVI are contradictory. Methods: Thirty‐five patients with MR graded ≥ 2+ were followed after undergoing TAVI with either the Edwards Sapien or CoreValve device. Echocardiography was performed the week before and 3 months after the procedure. MR was graded on a scale of 0 to 4+, classified as organic or functional, and the effective regurgitant orifice area (EROA) and MR index were calculated. Results: At baseline, MR was graded 4+ in 4 (11.4%) patients, 3+ in 10 (28.6%), and 2+ in 21 (60%). At follow‐up, MR was graded at 3+ in 4 (11.4%) patients, 2+ in 8 (22.9%), and 1+ in 19 (54.3%); 4 (11.4%) exhibited no MR. EROA (24.4 ± 11.5 mm2 pre‐TAVI vs. 11.2 ± 10.3 mm2 post‐TAVI, P < 0.001) and MR index (1.9 ± 0.3 pre‐TAVI vs. 1.3 ± 0.7 post‐TAVI, P < 0.001) were reduced with TAVI, independent of the etiology. MR decreased by at least 1 grade in 28 (80%) patients, with a reduction ≥2 grades in 10 (28.6%) patients; no patient showed a worsened condition. Subgroup analyses showed that the reduction in MR was significant in patients treated with the Edwards Sapien device but not in patients treated with the CoreValve device. Conclusions: This multiparametric echocardiographic evaluation showed that MR improved significantly after TAVI and that this result may be related to the type of valve implanted.Keywords
This publication has 18 references indexed in Scilit:
- Mitral Regurgitation in Patients Referred for Transcatheter Aortic Valve Implantation Using the Edwards Sapien Prosthesis: Mechanisms and Early Postprocedural ChangesJournal of the American Society of Echocardiography, 2012
- Transcatheter aortic implantation of the Edwards-SAPIEN bioprosthesis: Insights on early benefit of TAVI on mitral regurgitationInternational Journal of Cardiology, 2011
- Influence of corevalve revalving system implantation on mitral valve functionCatheterization and Cardiovascular Interventions, 2011
- European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)European Heart Journal - Cardiovascular Imaging, 2010
- Transcatheter aortic valve implantation for high risk patients With severe aortic stenosis using the Edwards Sapien balloon‐expandable bioprosthesis: A single centre study with immediate and medium‐term outcomesCatheterization and Cardiovascular Interventions, 2009
- Changes in mitral regurgitation after transcatheter aortic valve implantationCatheterization and Cardiovascular Interventions, 2009
- Mitral regurgitation in patients with aortic stenosis undergoing valve replacementHeart, 2009
- Changes in Mitral Regurgitation After Replacement of the Stenotic Aortic ValveThe Annals of Thoracic Surgery, 2008
- Aortic Valve Replacement and Concomitant Mitral Valve Regurgitation in the ElderlyCirculation, 2005
- The mitral regurgitation index: an echocardiographic guide to severityJournal of the American College of Cardiology, 1999